PUBLIC RELEASE DATE: <\/p>\n
3-Sep-2014 <\/p>\n
Contact: Ron Gilmore rlgilmore1@mdanderson.org<\/a> 713-745-1898 University of Texas M. D. Anderson Cancer Center<\/p>\n Parents of twins often tell them apart through subtle differences such as facial expression, moles, voice tone and gait. Similarly, physicians treating women with endometrial cancer must be able to distinguish between different versions of this disease form that, on the surface, appear the same. <\/p>\n With endometrial cancer, the most common gynecological cancer in the western world and the fourth most prevalent in the U.S., it can literally be a matter of life and death. Mortality rates from this cancer have nearly tripled in the last 25 years and are thought to be attributed to the rising incidence of obesity. <\/p>\n Scientists at The University of Texas MD Anderson Cancer Center in Houston have identified genetic mutations in endometrioid endometrial carcinoma (EEC), the most common form of this cancer of the uterine lining. The mutations revealed a more lethal version of an EEC subtype previously thought to respond well to treatment. It's possible that by identifying these patients early on, oncologists can try more aggressive treatment approaches to increase the likelihood for a positive outcome. <\/p>\n \"EEC is categorized into subtypes that help determine risk of recurrence and guide treatment,\" said Wei Zhang, Ph.D., professor of pathology at MD Anderson. \"Most patients have Type I, which can be diagnosed early and generally has a good outcome with treatment.\" <\/p>\n Type I accounts for 70 to 80 percent of all EECs. Type II is more troublesome and is usually diagnosed late in the cancer's progression resulting in a poor prognosis. Zhang's team, however, identified a cluster of patients within Type I that appears to have a more virulent form of it previously not recognized. Zhang labeled this patient group as Cluster II. <\/p>\n \"The patients were mostly younger and obese that's typical for Type I. What's unusual is for patients in this disease category to have decreased survival rates,\" said Zhang. \"Molecular subtyping of EEC may help oncologists with diagnosis and prognosis within this unique subset.\" <\/p>\n Zhang believes that by being able to identify molecular \"attributes,\" physicians can identify EEC patients at risk for this more lethal form of the disease. <\/p>\n <\/p>\n Excerpt from:<\/p>\n Genetic 'hotspot' linked to endometrial cancer aggressiveness<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" PUBLIC RELEASE DATE: 3-Sep-2014 Contact: Ron Gilmore rlgilmore1@mdanderson.org<\/a> 713-745-1898 University of Texas M. Continue reading